PENTOXIFYLLINE PREVENTS CONCANAVALIN A-INDUCED HEPATITIS BY REDUCING TUMOR-NECROSIS-FACTOR-ALPHA LEVELS AND INHIBITING ADHESION OF T-LYMPHOCYTES TO EXTRACELLULAR-MATRIX
H. Shirin et al., PENTOXIFYLLINE PREVENTS CONCANAVALIN A-INDUCED HEPATITIS BY REDUCING TUMOR-NECROSIS-FACTOR-ALPHA LEVELS AND INHIBITING ADHESION OF T-LYMPHOCYTES TO EXTRACELLULAR-MATRIX, Journal of hepatology, 29(1), 1998, pp. 60-67
Background/Aims: ConcanavaIin A activates T lymphocytes and causes T c
ell-mediated hepatic injury in mice. Tumor necrosis factor alpha is a
critical mediator in this experimental model. T-cell-mediated liver in
jury involves the migration of immune cells, notably CD4(+) T lymphocy
tes, into liver tissue. Pentoxifylline is a strong suppresser of tumor
necrosis factor a release and prevents leukocyte adherence to vascula
r endothelium and down-regulates the expression of intercellular adhes
ion molecule-1 in monocytes. In this study we examined the efficacy of
pentoxifylline as a potential therapeutic compound for the treatment
of concanavalin A hepatitis. Methods: Balb/c mice were injected with 1
2 mg/kg concanavalin A with or without a single injection of pentoxify
lline (5-300 mg/kg), 2 h prior to concanavalin A administration. Liver
damage was evaluated by determining serum levels of liver enzymes and
tumor necrosis factor alpha, and hepatic histopathology compared to m
ice treated with concanavalin A only. We also assessed the effects of
pentoxifylline on the adhesive properties of T lymphocytes to fibronec
tin, as a paradigm for immune cell-extracellular matrix interactions r
equired for migration. Results: Pretreatment with pentoxifylline signi
ficantly reduced serum levels of liver enzymes (3800+/-650 vs 150+/-28
IU/I) and tumor necrosis factor alpha (710+/-105 vs 113+/-15 pg/ml) w
ith no evidence of inflammation in histopathologic examination compare
d to control mice treated with concanavalin A. Pentoxifylline also inh
ibited the binding of murine T cells to fibronectin. All the effects o
f pentoxifylline were dose-dependent. Conclusions: These results indic
ate that high doses of pentoxifylline can prevent concanavalin A hepat
itis by suppression of tumor necrosis factor alpha release and inhibit
ion of T cells adhesion to extracellular matrix.